(Alliance News) - RTW Biotech Opportunities Ltd said on Friday said it is participating in a EUR65 million Series A financing round for Alesta Therapeutics BV, a Leiden, Netherlands-based ...

Multiple end-usage of membrane chemicals is creating demand across several industries including electric power, oil & gas, food &beverage, pulp and p ...

A phase 3 trial reveals that combining brentuximab vedotin with lenalidomide and rituximab improves survival in relapsed ...

The hospital in Bengaluru declined to provide him with ₹5 lakh cover under the Ayushman Bharat Pradhan Mantri Jan Arogya ...

Probiotics are "good" bacteria, but they may not be the best option to get rid of the bacteria when you have BV. Our experts ...

A retired 72-year-old Bengaluru man diagnosed with cancer committed suicide after being denied medical benefits under ...

Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced that data from ...

His Royal Highness Prince William officially opened the Oak Cancer Centre at The Royal Marsden NHS Foundation Trust in Surrey ...